| Bayer
CropScience Limited
UNAUDITED FINANCIAL
RESULTS FOR THE PERIOD ENDED 30TH JUNE, 2008
|
| Rs. in Lacs |
| PARTICULARS |
THREE
MONTHS
ENDED
30th JUNE
2008
|
CORRESPONDING
THREE MONTHS
ENDED
30th JUNE 2007
IN THE PREVIOUS
YEAR |
YEAR TO DATE
FIGURES FOR
THE PREVIOUS
YEAR FROM 1st
JANUARY 2007
TO 30th JUNE
2007 |
PREVIOUS
ACCOUNTING
PERIOD FROM
1st JANUARY 2007
TO 31st MARCH
2008 |
| Income |
|
|
|
|
| Net Sales/
Income from Operations |
49,538 |
32,431 |
46,294 |
123,832
|
| Other Income |
496
|
753 |
1,093 |
2,304 |
| Total Income |
50,034
|
33,184 |
47,387 |
126,136 |
| |
| Expenditure
|
| (Increase)/ Decrease
in Stock in Trade and Work in Progress |
(8,481) |
(2,547) |
(5,324) |
(1,065) |
| Consumption of Raw
Materials |
7,665 |
4,366 |
11,760 |
31,781 |
| Purchase of traded
goods |
34,049 |
21,645 |
25,054 |
46,518 |
| Employees cost |
3,093 |
2,165 |
4,137 |
12,217 |
| Depreciation |
586 |
509 |
1,023 |
2,612 |
|
Impairment loss of fixed assets (net)
|
-
|
- |
- |
16 |
| Other Expenditure |
7,601 |
5,506 |
9,398 |
25,563 |
| Total Expenditure |
44,513 |
31,644 |
46,048 |
117,642 |
| |
|
|
|
|
| Interest |
132
|
70 |
184 |
589 |
| Exceptional Items (net) |
- |
(1,940) |
(1,940) |
1,110 |
| |
- |
- |
- |
683 |
Profit from Ordinary
Activities before tax
|
5,389 |
3,410 |
3,095 |
6,795 |
Tax Expense (including Deferred Tax and Fringe Benefit
Tax)
|
(1,915)
|
(823) |
(770) |
(1,885) |
Net Profit from Ordinary Activities after tax
|
3,474 |
2,587 |
2,325 |
4,910 |
|
.
|
.
|
.
|
.
|
Paid up Equity Share Capital (Face Value Rs. 10)
|
3,950
|
3,950
|
3,950
|
3,950
|
| . |
.
|
.
|
.
|
.
|
Reserves excluding Revaluation Reserve
as per Balance sheet of previous accounting year
|
- |
- |
- |
32,994 |
.
|
.
|
.
|
.
|
.
|
Earning Per Share (basic
& diluted) (not annualised)
|
8.79
|
6.55 |
5.89 |
12.43 |
| Public Shareholding.
|
| Number of shares |
11,412,085
|
11,412,085
|
11,412,085
|
11,412,085
|
| Percentage of shareholding (%) |
28.89%
|
28.89%
|
28.89%
|
28.89%
|
| Notes:
1. The above results have been reviewed and recommended
by the Audit Committee and approved by the Board of
Directors of the Company at its meeting held on 24th
July, 2008.
2. In accordance with the past practice consistently
followed, Sales for the three months ended 30th June,
2008 are net of estimated returns of Rs. 7,294 lacs
(Jan - June 2007 Rs. 3,550 lacs), in respect of seasonal
sales which in the Management’s opinion, may
need to be reviewed dependent on future circumstances.
Further, sales returns are accounted at actuals at
the financial year end.
3. Exceptional Items for -
(a) the quarter and six months ended 30th June, 2007
and fifteen months ended 31st March 2008, includes
profit of Rs. 1,555 lacs on sale of equity shares
in Bayer Diagnostics India Limited, pursuant to the
global divestment of Diagnostics business by Bayer
AG to Siemens AG and profit of Rs. 385 lacs on sale
of equity shares in Bayer Polychem (India) Limited,
a wholly owned subsidiary.
(b) the fifteen months ended 31st March, 2008 also
includes expenditure on account of Voluntary Retirement
offered to and accepted by 119 employees at Thane
aggregating Rs. 3,050 lacs.
4. The Company has only one reportable business segment,
i.e. “Agri Care”.
5. There were no investor complaints pending at the
beginning and at the end of the quarter. The Company
has received four investor’s complaints during
the quarter and have been resolved.
6. Previous period’s figures have been regrouped
wherever necessary.
|
Place: Mumbai
Date: 24th July, 2008
|
By Order of the
Board
Stephan Gerlich
Vice Chairman and
Managing Director |
|
